今年以来，生物医药B类股强势非常，是港股市场备受青睐的概念之一，板块内多达26只概念股录得翻倍上涨，科伦博泰生物-B（06990.HK）、乐普生 物-B（02157.HK）、和铂医药-B（02142.HK）等多股迎来飙升。 而在IPO市场，还有更多创新药企正赶赴港股市场，其中就包括于近期递表的BlissBio Inc.（以下简称"百力司康"），高盛、华泰国际、建银国际是此次 IPO的联席保荐人。 已获多轮融资，高瓴参与投资 说起百力司康就不得不提及其创始人魏紫萍博士和周宇虹博士，这两位创始人均拥有亮眼的学术背景与丰富的业界经验。 根据招股书，魏紫萍博士先后获中国科学技术大学化学学士、新泽西州立罗格斯大学的化学博士学位，曾在阿斯利康（AZN.US）、百时美施贵宝等药企 从事研发和管理相关的工作，在制药业拥有逾25年的药品研发经验。 周宇虹博士先后获得复旦大学生物化学学士学位及遗传学硕士学位、新泽西州立罗格斯大学微生物学及分子遗传学博士学位，曾在Morphotek,Inc.担任抗 体开发高级总监，拥有逾25年的靶向治疗及免疫治疗研发经验。 2017年，魏紫萍博士和周宇虹博士创办了百力司康，总部位于杭州。百力司康是 ...

Core Insights - The report emphasizes the importance of discovering investment opportunities with a proactive attitude rather than merely relaying information [1] Macro News Summary - The Ministry of Commerce is promoting the expansion of pilot programs in the telecommunications and healthcare sectors, while also cautiously expanding self-initiated openings in education and culture [4] - The central government has set new directions for urban development, focusing on urban renewal and real estate development [5] Industry Latest Developments - A record high for single order amounts has been achieved, indicating a potential acceleration in the commercialization of the low-altitude economy, with related stocks including Nanjing Julong (300644) and Yingboer (300681) [6] - The national maximum electricity load has reached a new historical high, suggesting continued positive performance for the electricity sector, with related stocks such as Shanghai Electric (600021) and Jinkong Electric (000767) [6] - A brain-computer interface technology developer conference is scheduled for August, which may catalyze related sectors, with stocks like Innovation Medical (002176) and Aipeng Medical (300753) being relevant [6] Company Focus - Chongda Technology (002815) is experiencing strong domestic and international order demand [7] - Guoxuan High-Tech (002074) has received EU battery regulation compliance certification for its 5MWh liquid-cooled energy storage system [7] - East Asia Machinery (301028) anticipates increased demand for air compressors and vacuum pumps due to accelerated domestic substitution processes [7] - Jinxin Technology (300252) has developed products compatible with Intel's next-generation platform Oak Stream (PCIE 6.0) [7] Market Review and Outlook - On July 17, the market experienced an overall upward trend, with the ChiNext Index leading gains. The total trading volume in the Shanghai and Shenzhen markets reached 1.54 trillion, an increase of 97.3 billion from the previous trading day [8] - The report highlights several investment opportunities, including: 1. Technology innovation sectors such as robotics, AI, semiconductors, and digital economy (digital currency), with a caution to avoid purely speculative stocks with high valuations [8] 2. Anti-involution sectors including photovoltaics, batteries, energy storage, new energy vehicles, building materials, coal, steel, and non-ferrous metals [8] 3. Areas benefiting from consumption upgrades and policies, including innovative pharmaceuticals, consumer healthcare, equipment upgrades, smart homes, cross-border e-commerce, and industrial upgrades [8]

Core Insights - The report highlights the significant growth potential in the measurement and calibration industry, driven by new policies aimed at enhancing manufacturing capabilities in China [6][7][8] - The renewable energy sector, particularly in electric power equipment, is poised for growth due to supportive policies in the UK and increasing demand for energy storage solutions [13] - The pharmaceutical industry is recommended for investment, focusing on innovative drugs and their supply chains, with strong support from health insurance reforms [14] Industry and Company Analysis - **Measurement and Calibration Industry**: The first policy document from the Ministry of Industry and Information Technology emphasizes the need for precise measurement to drive innovation in manufacturing. This includes establishing a service network and digital transformation paths, with a focus on high-level calibration institutions and digital measurement software [6][7] - **Renewable Energy Sector**: The UK government has restarted subsidies for electric vehicles and charging infrastructure, indicating a robust market for energy storage systems. The report suggests focusing on companies involved in battery production and charging infrastructure, such as Ningde Times and Keda Technology [13] - **Pharmaceutical Industry**: The report continues to recommend innovative drug sectors, highlighting the recent adjustments in health insurance and commercial insurance that favor high-value innovative drugs. Companies like Kelun-Biotech and Innovent Biologics are noted for their strong potential in both domestic and international markets [14] - **Oil and Gas Sector**: China National Offshore Oil Corporation (CNOOC) has made significant advancements in oil and gas exploration, achieving record production levels in both domestic and international operations. The report anticipates continued growth in production capacity, particularly in the Stabroek block in Guyana [20][21][24]

Group 1 - The adjustment of the medical insurance catalog and commercial health insurance innovative drug catalog has officially started, providing stronger economic support for the development of innovative drugs in China [1] - Domestic and overseas markets for innovative drugs are showing continuous improvement, with promising clinical data presented at academic conferences such as ASCO and ADA [1] - The trend of Chinese innovative drugs going abroad is strengthening as their clinical data and progress become increasingly competitive globally [1] Group 2 - The CXO industry is experiencing a recovery, with prices in preclinical CRO, clinical CRO, and domestic CDMO businesses stabilizing, and new orders steadily recovering [2] - The international CDMO business maintains a reasonable pricing system, and the impact of high pandemic baselines has been digested, indicating a potential industry reversal [2] - Chinese companies have comprehensive advantages in the small molecule CRDMO sector, and their industry position is unlikely to be shaken in the medium term [2][3] Group 3 - The overall market share of Chinese companies in the large molecule CRDMO sector remains low, facing strong competition from international players [3] - The rapid development of new molecular businesses such as peptides, oligonucleotides, and CGT is expected to further open up growth opportunities in the CXO sector [3]

Group 1: Report Industry Investment Rating - No information provided on the report industry investment rating Group 2: Core View - On July 17, all four major stock index futures contracts for the current month rose. IF rose 0.74%, IH rose 0.37%, IC rose 1.17%, and IM rose 1.41%. The overall sentiment in the stock index futures market remains positive in the absence of negative news [1]. - The total trading volume of stock index futures rebounded on this trading day, indicating an increase in investors' trading enthusiasm. The A - share market fluctuated upwards, with the ChiNext Index surging, and theme stocks blooming in multiple areas. The computing power industry chain led the gains [1][2][6]. Group 3: Summary by Relevant Catalogs 3.1期指期现数据跟踪 - **IF Contracts**: The closing prices of IF2507, IF2508, IF2509, and IF2512 all rose, with increases of 0.74%, 0.90%, 0.93%, and 0.86% respectively. The trading volumes of IF2507 decreased by 3881, while those of IF2508, IF2509 increased by 6646 and 4243 respectively. The open interests of IF2507 decreased by 8803, while those of IF2508, IF2509, and IF2512 increased [1]. - **IH Contracts**: The closing prices of IH2507, IH2508, IH2509, and IH2512 all rose, with increases of 0.37%, 0.36%, 0.39%, and 0.42% respectively. The trading volume of IH2507 decreased by 2826, while those of IH2508 increased by 4245. The open interests of IH2507 decreased by 4717, while those of IH2508, IH2509, and IH2512 increased [1]. - **IC Contracts**: The closing prices of IC2507, IC2508, IC2509, and IC2512 all rose, with increases of 1.17%, 1.27%, 1.33%, and 1.31% respectively. The trading volume of IC2507 decreased by 9192, while those of IC2508, IC2509, and IC2512 increased. The open interests of IC2507 decreased by 13453, while those of IC2508, IC2509, and IC2512 increased [1]. - **IM Contracts**: The closing prices of IM2507, IM2508, IM2509, and IM2512 all rose, with increases of 1.41%, 1.42%, 1.42%, and 1.38% respectively. The trading volume of IM2507 decreased by 5989, while those of IM2508, IM2512 increased. The open interests of IM2507 decreased by 11744, while those of IM2508, IM2509, and IM2512 increased [1]. 3.2期指前20大会员持仓增减 - For IF contracts, the long - position changes varied among different contracts. For example, IF2507 had a decrease of 5135 in long - positions, while IF2508 had an increase of 7879. The short - position changes also differed, such as IF2507 having a decrease of 5921 [5]. - For IH contracts, IH2507 had a decrease of 3596 in long - positions and a decrease of 3491 in short - positions. IH2508 had an increase of 4081 in long - positions and an increase of 4524 in short - positions [5]. - For IC contracts, IC2507 had a decrease of 9941 in long - positions and a decrease of 10434 in short - positions. IC2508 had an increase of 7871 in long - positions and an increase of 7792 in short - positions [5]. - For IM contracts, IM2507 had a decrease of 7609 in long - positions and a decrease of 8680 in short - positions. IM2508 had an increase of 7929 in long - positions and an increase of 8536 in short - positions [5]. 3.3趋势强度 - The trend strength of IF and IH is 1, and the trend strength of IC and IM is also 1. The trend strength ranges from - 2 to 2, with - 2 being the most bearish and 2 being the most bullish [6]. 3.4重要驱动 - Potential Fed Chairman candidate Kevin Warsh believes that Trump's public pressure on the Fed is correct. The Fed has stepped into policy areas beyond its scope under Powell's leadership and should not overly worry about inflation caused by Trump's tariffs [6]. - The EU is drafting a tariff list on US service industries in preparation for an escalation of the trade war. If negotiations fail, the EU plans to levy fees on US digital services such as advertising services [6]. - The A - share market fluctuated upwards. The Shanghai Composite Index rose 0.37%, the Shenzhen Component Index rose 1.43%, and the ChiNext Index rose 1.75%. The A - share trading volume reached 1.56 trillion yuan, compared with 1.46 trillion yuan the previous day. The computing power industry chain exploded again, with CPO and PCB sectors leading the gains [6].

鹏华产业升级混合型证券投资基金 基金管理人：鹏华基金管理有限公司 基金托管人：宁波银行股份有限公司 报告送出日期：2025 年 7 月 18 日 鹏华产业升级混合 2025 年第 2 季度报告 §1 重要提示 基金管理人的董事会、董事保证本报告所载资料不存在虚假记载、误导性陈述或重大遗漏， 并对其内容的真实性、准确性和完整性承担个别及连带的法律责任。 基金托管人宁波银行股份有限公司根据本基金合同规定，于 2025 年 07 月 17 日复核了本报告 中的财务指标、净值表现和投资组合报告等内容，保证复核内容不存在虚假记载、误导性陈述或 者重大遗漏。 基金管理人承诺以诚实信用、勤勉尽责的原则管理和运用基金资产，但不保证基金一定盈利。 基金的过往业绩并不代表其未来表现。投资有风险，投资者在作出投资决策前应仔细阅读本 基金的招募说明书及其更新。 本报告中财务资料未经审计。 本报告期自 2025 年 04 月 01 日起至 2025 年 06 月 30 日止。 §2 基金产品概况 基金简称 鹏华产业升级混合 基金主代码 011568 基金运作方式 契约型开放式 基金合同生效日 2021 年 9 月 2 日 报告期末基金 ...

Market Sentiment - The current market sentiment score is 84, indicating an "overheated" market condition [2][10][21] - Historical trends show that when sentiment is below or near 30, the market tends to find support, while above 90, resistance is likely [10] Hot Themes Tracking - **Robotics Theme**: The government is promoting entrepreneurship, with significant contracts awarded for humanoid biped robots, totaling 124 million yuan. Related stocks include Wolong Electric Drive and Changsheng Bearing [7] - **RDA Theme**: The Shanghai Data Exchange has introduced the RDA paradigm, emphasizing the integration of real data assets with physical assets. Related stocks include Tongxingbao and Wanda Information [7] - **Innovative Pharmaceuticals Theme**: New measures from the National Healthcare Security Administration support the use of medical insurance data in drug development. Related stocks include Heng Rui Medicine and Betta Pharmaceuticals [7] Capital Flow Analysis - **Net Inflow**: The top ten stocks with the highest net inflow include Changshan Beiming and Runhe Software, with inflows of 201 million yuan and 93 million yuan respectively [11] - **Net Buy in Financing**: New Yi Sheng leads with a net buy of 56 million yuan, followed by Changshan Beiming with 34 million yuan [12] - **Net Outflow**: The top ten stocks with the highest net outflow include Zhongdian Port and ST Huatuo, with outflows of 51 million yuan and 39 million yuan respectively [13] Industry Insights - The computer and electronic sectors are currently attracting significant capital inflow, while industries like banking and environmental protection are experiencing net outflows [16][17][22]

Group 1 - A-shares are expected to maintain a trend of oscillating upward, with the market transitioning from a "weight-based" to a "theme-based" approach, focusing on structural opportunities in recent hot sectors [2] - The three major A-share indices closed higher, with the ChiNext index showing strong performance, while sectors like computing hardware and innovative pharmaceuticals led the gains [2] - Long-term capital inflow is accelerating, with ETF sizes steadily increasing and insurance funds providing significant support to the market [3] Group 2 - The domestic economy is stabilizing, and liquidity is being released through rate cuts, which may enhance market activity in both A-shares and Hong Kong stocks [3] - The new regulations in the securities industry are expected to boost revenue growth for brokerage firms, while long-term insurance policies may improve investment returns and valuations [3] - The market is currently in a new buying window, with improved investor sentiment and incoming capital, although it faces resistance at higher levels [2]

研究早观点 2025 年 7 月 18 日 星期五 市场走势 资料来源：最闻 国内市场主要指数 | 指数 | | 收盘 | 涨跌幅% | | --- | --- | --- | --- | | 上证指数 | | 3,516.83 | 0.37 | | 深证成指 | | 10,873.62 | 1.43 | | 沪深 | 300 | 4,034.49 | 0.68 | | 中小板指 | | 6,771.93 | 1.77 | | 创业板指 | | 2,269.33 | 1.75 代，半导体、具身智能等持续突破 | | 科创 | 50 | 1,005.65 | 0.80 | 资料来源：最闻 分析师： 李明阳 执业登记编码：S0760525050002 邮箱：limingyang@sxzq.com 【今日要点】 【行业评论】通信：周跟踪（20250707-20250713）-——Grok4、KIMI K2 发布，算力板块业绩预告亮眼 【行业评论】生物医药Ⅱ：创新药动态更新：PD-1/VEGF/CTLA-4 三抗 CS2009：剂量爬坡耐受性良好，冷肿瘤及 PD-(L)1 经治患者中观察到抗肿 瘤活性 【行业评论】煤 ...

Group 1 - A-shares showed positive performance on July 17, with trading volume exceeding 15,100 and average stock prices rising, indicating potential upward momentum, although there is uncertainty about reaching the previous high of 3,555.22 points [1] - The Sci-Tech Innovation Board 50 Index had a smaller increase but has shown signs of recovery; if it accelerates upward, it could indicate effective sector rotation, though this does not guarantee sustained strength in the Shanghai Composite Index [1] - The banking sector has experienced consecutive declines, and if it rebounds, the index may rise directly; however, there is currently no significant indication of a major adjustment in the index [1] Group 2 - Recent strength in sectors such as CPUs and optical communication modules is expected to enter a consolidation phase soon, while innovative pharmaceuticals and medical sectors have shown strong performance, but their sustainability is in question [1] - The photovoltaic sector had performed well recently, and there are signs of strength in battery, new energy, and automotive parts sectors; however, the index is not expected to rise significantly, maintaining a rotational pattern with short-term uncertainty [2] - The current market presents numerous opportunities, and maintaining a certain level of position is advised to avoid being caught off guard by potential upward acceleration in the index [2]